Table 3.
Virus | HCoV-229E | HCoV-NL63 | HCoV-OC43 | HCoV-HKU1 | SARS-CoV | MERS-CoV | SARS-CoV-2 |
---|---|---|---|---|---|---|---|
Genus | Alphacoronavirus | Betacoronavirus | |||||
Disease | Mild respiratory tract infections | Mild respiratory tract infections and pneumonia | Severe acute respiratory syndrome | Middle East respiratory syndrome | Coronavirus disease 2019 | ||
Natural host | Bats | Rodents | Bats | ||||
Intermediate host | Camelids? | Unidentified | Bovines | Unidentified | Palm civets | Dromedary camels | Unidentified |
Transmission | Respiratory droplets, aerosols, and fomites | Respiratory droplets, aerosols, fomites and fecal–oral | Respiratory droplets and fomites | Respiratory droplets, aerosols, fomites, and fecal–oral (?) | |||
Incubation period (days) | 2–5 | 2–4 | 2–5 | 2–4 | 2–11 | 2–13 | 1–14 |
Signs and symptoms | Fever, nasal discharge, sneezing, cough, malaise headache, and sore throat | Fever, dry cough, headache, myalgia, malaise, dyspnea, respiratory distress, and diarrhea | Fever, nasal discharge, sneezing, cough, malaise headache, and sore throat | Fever, cough, running nose, and dyspnea | Fever, headache, dry cough, dyspnea, respiratory distress, malaise, myalgia, and diarrhea | Fever, cough, myalgia, chills, sore throat, dyspnea, pneumonia, arthralgia, diarrhea, vomiting, and acute renal impairment | Fever, dry cough, headache, dyspnea, myalgia, respiratory distress, renal impairment, diarrhea, multiple organ failure |
Case fatality | N/A | N/A | N/A | N/A | 9.6% | 34.4% | 3.5% |
Epidemiology | Peak in winter globally | 2002–03 in China, then Globally to 29 countries | 2012 in Middle East, 2015 in South Korea, and Endemic in Middle East |
2019–2020 in China, then progressed to a global pandemic. | |||
References | [161,162,163,164,165,166,167] | [168,169,170,171,172,173] | [165,174] | [174,175] | [176,177,178,179,180,181,182,183] | [184,185,186,187,188,189,190,191,192,193,194,195,196] | [155,197,198,199] |